| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Evofem Biosciences, Inc. (EVFM) has 0 insiders with recent SEC Form 4 filings, including 1 buy and 7 sells. EVFM is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 17, 2015 | Locke Kenneth W | Chief Scientific Officer | Sell | 598 | $1.26 | $753.48 | -100% | |
| Dec 17, 2015 | Knudson Susan A. | Chief Financial Officer | Sell | 1,005 | $1.26 | $1,266.30 | -100% | |
| Dec 15, 2015 | Alta Partners Viii, L.P. | 10% Owner | Sell | 529,261 | $1.44 | $762,135.84 | -19.8% | |
| Nov 18, 2015 | Locke Kenneth W | Chief Scientific Officer | Sale+OE | 6,098 | $8.30 | $50,619.50 | -95.4% | |
| Sep 18, 2015 | Kemmerer Christopher | VP, Pharma Dev &Manufacturing | Sale+OE | 1,000 | $12.20 | $12,195.00 | -8.4% | |
| Sep 1, 2015 | Knudson Susan A. | Chief Financial Officer | Sale+OE | 3,000 | $11.33 | $33,990.00 | -85.9% | |
| Aug 7, 2015 | Kemmerer Christopher | VP, Pharma Dev &Manufacturing | Sale+OE | 1,000 | $12.88 | $12,880.00 | -8.4% | |
| Mar 19, 2015 | Mahaffey George W | President And CEO | Buy | 1,000 | $7.76 | $7,756.90 | +0.5% |